ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08905
-0,04%
Bitcoin
67.164,45
0,33%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) News

OPK

Opko Health (OPK)

Opko Health Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPK
DatumZeitQuelleÜberschriftSymbolFirma
07/05/202422h29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
07/05/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
07/05/202422h05GlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
03/05/202414h00GlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
28/03/202413h00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
20/03/202413h00GlobeNewswire Inc.Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel SyndromeNASDAQ:OPKOpko Health Inc
07/03/202422h02Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:OPKOpko Health Inc
05/03/202414h52GlobeNewswire Inc.AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIVNASDAQ:OPKOpko Health Inc
01/03/202422h05Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:OPKOpko Health Inc
28/02/202415h31PR Newswire (US)NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1stNASDAQ:OPKOpko Health Inc
27/02/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
27/02/202422h05GlobeNewswire Inc.OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
22/02/202422h05GlobeNewswire Inc.OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024NASDAQ:OPKOpko Health Inc
16/02/202422h53Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPKOpko Health Inc
09/02/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
05/02/202414h09PR Newswire (US)NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in ChinaNASDAQ:OPKOpko Health Inc
29/01/202421h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
24/01/202422h15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:OPKOpko Health Inc
24/01/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
17/01/202423h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
10/01/202423h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
09/01/202423h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
09/01/202422h05GlobeNewswire Inc.OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional NotesNASDAQ:OPKOpko Health Inc
08/01/202415h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
08/01/202414h00GlobeNewswire Inc.OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OPKOpko Health Inc
05/01/202423h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
05/01/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
05/01/202419h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
05/01/202418h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
05/01/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
 Showing the most relevant articles for your search:NASDAQ:OPK

Kürzlich von Ihnen besucht

NASDAQ
FUVLFX
Water Utility and Infras...
BIT
UB4QCY
Unicredit Bank
USOTC
MCIAF
Mercia Asset Management (PK)
COIN
WGRTUST
WaykiChain Governance Coin
AMEX
ENX
Eaton Vance New York Mun...
USOTC
CCYNF
Cyan (GM)
USOTC
PORBF
Pola Orbis (PK)
AMEX
MLPO
Credit Suisse S&P MLP In...
LSE
UB74
Ubsetf Ut1gba
TSX
9334
Ibis
COIN
MLKKRW
Mil.k Coin
NASDAQ
BULKU
Navios Maritime
BIT
F19592
Vontobel Financial Produ...
USOTC
CLVSF
Cellavision AB Foreign (PK)
USOTC
MMMPF
Mermaid Maritime Public (PK)
EU
CDCIY
SCES Cdc 1.474% 05/06/49
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten